



Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FucT-VIII Double Nickase Plasmid (h) | sc-402957-NIC | 20 µg | $410.00 | |||
FucT-VIII Double Nickase Plasmid (h2) | sc-402957-NIC-2 | 20 µg | $410.00 |
Human FUT8 encodes α1,6-fucosyltransferase (FucT-VIII), the Golgi-localized enzyme that catalyzes core fucosylation of N-linked glycans on glycoproteins. This modification is a key determinant of glycoprotein maturation, receptor–ligand interactions, and downstream signal transduction, influencing processes such as cell adhesion, immune receptor function, and growth factor signaling. FUT8 activity integrates with the N-glycosylation pathway and cellular trafficking through the secretory pathway, shaping protein stability and surface presentation. Dysregulated core fucosylation has been associated with altered signaling networks and glycoprotein remodeling observed in multiple disease-relevant contexts, including inflammation and oncogenic transformation.
FucT-VIII Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the FUT8 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within FUT8. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt FUT8 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of FUT8-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.